Post-Authorization Long-Term Safety Study of LUTATHERA

NCT03691064 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

1014

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DRUG: LUTATHERA

Sponsor

Advanced Accelerator Applications